Nicotinic acetylcholine receptor alpha4 subunit gene polymorphism and attention deficit hyperactivity disorder

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Attention deficit hyperactivity disorder (ADHD) is a common, highly heritable childhood disorder.
• Evidence suggests the nicotinic system plays a role in ADHD, with nicotine improving attention and ADHD linked to smoking behaviors.
• The nicotinic acetylcholine alpha 4 receptor (CHRNA4) is a potential target, as indicated by studies with nicotinic agonists.

Purpose of the Study:

• To examine if a specific polymorphism (Cfol) in the CHRNA4 gene is associated with ADHD susceptibility.
• To investigate the role of the nicotinic acetylcholine alpha 4 receptor in the genetic basis of ADHD.

Main Methods:

• Studied 70 ADHD parent-proband trios with children aged 6-12 diagnosed with ADHD.
• Analyzed a known Cfol polymorphism within the CHRNA4 gene.
• Utilized the Transmission Disequilibrium Test (TDT) to assess allele transmission patterns.

Main Results:

• The Transmission Disequilibrium Test showed no significant evidence linking the CHRNA4 Cfol polymorphism to ADHD susceptibility.
• The P-value for the association was greater than 0.35, indicating a lack of statistical significance.

Conclusions:

• The studied Cfol polymorphism in the CHRNA4 gene does not appear to influence susceptibility to ADHD.
• Further research with larger sample sizes is needed to explore other nicotinic system polymorphisms in ADHD.